Alzheimer's Drug
-
Experimental Alzheimer’s drug slows disease, researchers say. Will it make a difference?An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday.HealthNov 30, 2022
-
Alzheimer’s drug shows signs of slowing disease in early results of global studyEisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer's.HealthSep 29, 2022
-
U.S. drugmaker Lilly to submit ‘breakthrough’ Alzheimer’s drug to FDAThe drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year.HealthJun 24, 2021
![]()
-
U.S. FDA approves 1st new Alzheimer’s drug in nearly 20 yearsIt's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.HealthJun 7, 2021
![]()
-
Company pushes Alzheimer’s drug amid conflicting resultsAducanumab's developers stopped two studies earlier this year because it didn’t seem to be working, then did a stunning about-face in October and said new results suggest it was effective at a high dose.ScienceDec 5, 2019
![]()
-
New drug shows promise in treating mild Alzheimer’s dementiaThe news comes out of the annual Alzheimer's Association International Conference.LifestyleJul 27, 2018
![]()
